SF company step closer to creating drug that could help dogs live longer; reaches FDA milestone
SAN FRANCISCO (KGO) -- A San Francisco-based company is working to launch a drug that could make dogs live longer and healthier lives.
Tuesday, the company called, Loyal, reached a major milestone in its work on the drug right now called LOY-001 which would be given in the form of a routine injection.
The company announced that the FDA gave it a "technical section complete."
That means that the FDA agrees with the data Loyal provided that shows the drug's effectiveness.
Loyal provided ABC7 the letter it received from the FDA notifying them.
MORE: More time with your pets? SF biotech company trying to create fountain of youth for dogs
It's a major step forward, but the company isn't past the finish line just yet.
"We can't sell the drug yet, you can't go ask your vet about it yet," said Celine Halioua, CEO of Loyal, "We still have to finish manufacturing and safety. But the "does it work?" is, kind of historically the most challenging and most complex aspect of getting a drug approved."
Work is also still being done to determine just how much longer it could extend a dog's life.
Loyal is also working on a similar drug, LOY-002, that would serve older dogs of nearly every size and breed.
And LOY-003 would be the same as LOY-001 but in pill form, something Halioua say is important for convenience and price accessibility, something she says is a priority for the company.
"This is not going to be a rich person drug, this is not going to be something that puts your family to bankruptcy," she said, "I don't know the final price yet. We're working on finalizing that but think double digits per month. It's not going to be thousands."
MORE: Tell aging to 'heel': How dogs could help scientists find the key to prolonging human life
The possibility of the drug is one that has some dog owners excited.
"He's only 11 months, I want him to live longer," Pierre Mabbayad said of his half-pit half-lab, "Because for bigger dogs, they don't live as long as the smaller ones, so I'm hoping that the research and the new drug that is getting tested works."
MORE: Meet Bobi, the oldest living dog in the world from southern Portugal
Others like German Shepherd owner Jilene Thompson said it wouldn't be for them.
"Using a drug? Absolutely not," she said, "I'm against drugs."
Halioua says she's heard criticisms but the larger feedback has been positive.
The company aims to have LOY-001 launched by 2026, LOY-002 by 2025 and LOY-003 by 2026. Learn more here.
If you're on the ABC7 News app, click here to watch live
